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Ⅰ．Introduction
 Regulatory T （T reg） cells are indispensable for 
immune tolerance and suppress excessive inflammation. 
In 1995, Dr. Sakaguchi’s group showed that CD4＋ 
CD25＋ T cells have immunosuppressive function in 
mice as antibody-mediated depletion of this population 
resulted in the development of autoimmune diseases
［1］. A few years later, his and Dr. Rudensky’s group 
independently reported that Foxp3 is the master 
transcription factor of CD4＋ CD25＋ T reg cells
［2,3］. Of note, mutations in FOXP3 gene in humans 
result in the development of immune dysregulation, 
polyendocrinopathy, enteropathy, X-linked （IPEX） 
syndrome; patients with IPEX syndrome acquire 
multiple autoimmune diseases, indicating the crucial role 
of Foxp3 in regulating immune responses. Over the last 
decade, there has been a tremendous interest in the field 
of T reg-related research and researchers have shown 
the importance of T reg cells not only in autoimmune 
diseases, but also in cancer［4］, metabolic disorders［5］, 
and transplantation［6］. 
Ⅱ． Transcription factors that enhance the 
Foxp3 expression under inflammatory 
conditions
 The expression of Foxp3 is a crucial step toward 
the development of T reg cells because the ectopic 
expression of Foxp3 is sufficient to induce suppressive 
capacity in conventional CD4＋ T cells［2］.  The 
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Abstract
Regulatory T （T reg） cells play critical roles in maintaining immune homeostasis, and the 
development of this unique T cell subset is dependent on the master transcription factor, Foxp3. The 
transcription of Foxp3 is tightly regulated by several regulatory elements. While there is accumulating 
evidence that multiple transcription factors promote Foxp3 expression at steady-state conditions, 
little is known about how Foxp3 expression is controlled under inflammatory conditions. Although 
the expression of Foxp3 is sufficient to induce the suppressor function in murine CD4＋ T cells, Foxp3-
binding proteins are required for the appropriate T reg suppressor function. Thus, the precise 
understanding of Foxp3-containing transcription complex is important for optimizing T reg cell-based 
therapy for autoimmune diseases. In this review, the molecular mechanisms underlying the regulation 
of Foxp3 expression, especially under inflammatory conditions, are summarized. Further, Foxp3 
partner proteins and T reg cell function are also discussed.
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transcription of Foxp3 is regulated by the promoter and 
three enhancers located within the conserved non-coding 
sequences named CNS1, 2, and 3. Zheng et al. generated 
three knockout mouse lines lacking Foxp3 CNS1, 2 or 3, 
and the analyses of these CNS knockout mice revealed 
that CNS1, 2, and 3 are indispensable for T reg cell 
differentiation in the peripheral tissues, T reg stability, 
and T reg cell differentiation initiation, respectively［7］. 
Recently, a new Foxp3 enhancer region named CNS0 
which works as a super enhancer has been defined［8］. 
As mentioned above, T reg cell differentiation in the 
periphery is mainly controlled by CNS1 and it is shown 
that Smad3 and NFAT are recruited to CNS1 upon TGF-
β and T cell receptor （TCR） stimulation, respectively
［9］. All-trans-retinoic acid （ATRA）, a vitamin A 
metabolite, also induces T reg cell differentiation by 
boosting the Smad3 signaling［10］and suppresses Th17 
cell differentiation. In addition, AP-1 activates CNS1 
and promotes T reg cell differentiation in the periphery
［11］. However, little is known about how Foxp3 
expression is regulated under inflammatory conditions 
such as colitis, because most of these studies were 
conducted under steady-state conditions. 
Ⅲ． Sox12 and peripherally induced T reg 
cells during colitis
 The author and colleagues have performed RNA-
seq analyses of T reg cells recovered from mice with 
dextran sodium sulfate colitis to find novel T reg cell-
related transcription factor（s） upregulated during 
colitis［12］. Among 56 genes which are differentially 
expressed in T reg cells of colitic mice, we focused on 
a transcription factor Sox12, a member of SoxC family 
which is composed of Sox4, Sox11, and Sox12. It has 
been shown that SoxC is critical for the development of 
the nerve system［13］. In addition to the developmental 
function, accumulating evidence indicates their roles 
in the immune system. For example, Kuwahara et 
al. demonstrated that Sox4 negatively regulates Th2 
differentiation by interfering with Gata-3 function［14］. 
On the other hand, Yoshitomi et al. have shown that 
Sox4 facilitates the development of CXCL13-producing 
helper T cells in autoimmune diseases in humans［15］. 
These results suggest the crucial roles of SoxC family 
members in the acquired immunity.
 We first analyzed the expression of SoxC family 
in CD4＋ T cells. In vitro, the expression of Sox12 
was induced, whereas the expression of Sox4 was 
dramatically reduced by TCR stimulation in both 
conventional CD4＋ T cells and T reg cells. In contrast, 
Sox11 was not expressed in CD4＋ T cells even after 
TCR stimulation. These findings suggest distinct roles 
of Sox4 and Sox12 in CD4＋ T cells. 
 We also found that while Sox12 knockout mice 
did not develop autoimmune diseases spontaneously, 
Sox12-deficient CD4＋ T cells were colitogenic in the T 
cell transfer model of colitis. Importantly, when Sox12-
deficient naïve T cells and wild type （WT） naïve T 
cells were co-transferred into lymphopenic RAG2 
knockout mice, Foxp3 positive cells in Sox12-deficient 
T cells were less frequent as compared to those in WT T 
cells, indicating the role of Sox12 in the differentiation 
of T reg cells in the peripheral tissue during colitis. 
Consistently, over-expression of Sox12 efficiently 
promoted Foxp3 expression in naïve CD4＋ T cells, and 
Sox12-mediated Foxp3 expression was still observed 
Fig. 1　 Signals up-regulating Foxp3 transcription under 
inflammatory conditions.
　NFAT is activated and recruited to the Foxp3 CNS1 
enhancer, when conventional CD4＋ T cells recognize their 
own antigen. In addition, activated NFAT also promotes 
Sox12 expression and this leads to further activation of 
the Foxp3 promoter region. ATRA-induced retinoic acid 
receptor （RAR） activation and TGF-β-mediated Smad3 
phosphorylation also support the expression of Foxp3 in 
the peripheral tissue under inflammatory conditions. 
　TSS: transcription start site. 
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even in the presence of antibody against TGF-β or IL-
2, both of which are important for the induction of T 
reg cells. In addition, Sox12-expressing cells showed 
the suppression function both in vitro and in vivo. 
Chromatin immunoprecipitation （ChIP） analyses and 
reporter assays revealed the direct effect of Sox12 in 
promoting Foxp3 induction by binding to the Foxp3 
promoter. These results suggest that TCR-mediated 
up-regulation of Sox12 during colitis favors T reg cell 
differentiation in the periphery and protects mice from 
excessive inflammation.
Ⅳ． Transcription factor partners of Foxp3 
in T reg cells
 Although the forced expression of Foxp3  is 
sufficient to induce suppressive T reg cells, other 
transcription factors that physically interact with Foxp3 
are required for optimal T reg function. Rudensky and 
his colleagues carried out a comprehensive analysis 
of Foxp3-binding proteins and showed that more than 
300 proteins could potentially associate with Foxp3
［16］. One of such partner proteins is Gata-3. A part 
of thymus-derived T reg cells express Gata-3; T reg-
specific Gata-3-deficient mice spontaneously develop 
autoimmune diseases such as colitis and dermatitis［16］. 
In addition to Gata-3, Eos, HDACs, RUNX1, NFAT, 
and NF-κB are also reported as partners of Foxp3
［17］. Intriguingly, T reg cells that lack any of these 
Foxp3-binding partners fail to exhibit normal suppressor 
function. A recent study has shown that Foxp3 serves as 
an activator when it is complexed with RELA, IKZF2, 
and KAT5. In contrast, Foxp3 functions as a repressor 
when complexed with EZH2, YY1, and IKZF3［18］. 
These findings lead to speculation that the transcription 
program controlled by Foxp3 is tightly regulated and 
each of the Foxp3-binding partners is required for the 
optimal transcriptional landscape of T reg cells.
Ⅴ．KAP1, a novel partner of Foxp3 in T reg cells
 Dr. Ziegler and his colleagues reported a novel 
FOXP3-interacting protein, FIK （FOXP3-interacting 
KRAB domain-containing protein） in human T reg cells
［19］. FIK is a novel splicing isoform of ZFP90 and acts 
as a bridging molecule that connects FOXP3 with KAP1 
（also known as TIF-1β / TRIM28）; the knock-down of 
FIK or KAP1 results in decreased suppression capacity 
in human T reg cells. 
 KAP1 is a member of the tripartite motif proteins 
and was originally reported as a chromatin remodeling 
factor. KAP1 is critical for heterochromatin structure 
and is highly related to suppressive H3K9me3 mark. 
For example, KAP1-mediated deposition of H3K9me3 
is an important mechanism to silence endogenous 
retroviral elements［20］. However, considering the 
interaction between FOXP3 and FIK/KAP1 in human 
T reg cells and based on a previous report showing anti-
inflammatory effects on conventional T cells［21］, we 
hypothesized that KAP1 has different roles in T reg 
cells.
 We generated T reg-specific KAP1-deficient mice 
（T reg∆KAP1） to address the mechanisms by which 
KAP1-Foxp3 complex regulates T reg development 
and function［22］. Interestingly, adolescent T reg∆KAP1 
mice showed a lymphoproliferative disease and lung 
inflammation although the development of T reg cells 
in the thymus was not disturbed. T reg∆KAP1 mice also 
exhibited elevated anti-nuclear antibody, suggesting 
that T reg∆KAP1 mice develop global loss of tolerance. 
Consistent with the phenotype observed in T reg∆KAP1 
mice, KAP1-deficient T reg cells had diminished 
suppression function both in vitro and in vivo. ChIP-
seq analyses revealed that almost half of genomic 
loci occupied with Foxp3 were also bound by KAP1. 
Intriguingly, most of these genes regulated by KAP1-
Foxp3 complex were immune-related genes, suggesting 
the critical role of KAP1 in T reg cells. For example, 
Prdm1  （encodes Blimp-1） is co-occupied with KAP1 
and Foxp3, and the expression of Blimp-1 is decreased 
in KAP1-deficient T reg cells. As a previous report 
showed important roles of Blimp-1 in the production 
of immuno-suppressive cytokine IL-10［23］, we 
analyzed IL-10 expression in T reg cells in T reg∆KAP1 
mice［22］. Although IL-10 production in spleen was 
comparable between the control and T reg∆KAP1 mice, 
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IL-10-producing T reg cells were reduced in the lung 
of T reg∆KAP1 mice where the spontaneous inflammation 
was observed. These results suggest that KAP1-Foxp3 
complex governs T reg suppressor function through the 
expression of T reg-associated genes （e.g. Prdm1）.
Ⅵ．Conclusion and perspectives
 Although the prognosis of autoimmune diseases is 
gradually improving, the patients must continue to take 
immune-suppressive agents including glucocorticoids 
for life; the long-term use of non-specific immune-
suppressive drugs can lead to adverse events such as 
serious infections. Researchers are now developing T 
reg cell-based therapy because this new therapeutic 
strategy is expected to have less toxicity. However, we 
need to improve this new therapy, as the efficacy is still 
insufficient. Further progress in T reg research field is 
expected to overcome the autoimmune diseases in the 
future.
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